229 related articles for article (PubMed ID: 30690463)
1. A practice of expert review by read-across using QSAR Toolbox.
Fukuchi J; Kitazawa A; Hirabayashi K; Honma M
Mutagenesis; 2019 Mar; 34(1):49-54. PubMed ID: 30690463
[TBL] [Abstract][Full Text] [Related]
2. Improvement of quantitative structure-activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge Project.
Honma M; Kitazawa A; Cayley A; Williams RV; Barber C; Hanser T; Saiakhov R; Chakravarti S; Myatt GJ; Cross KP; Benfenati E; Raitano G; Mekenyan O; Petkov P; Bossa C; Benigni R; Battistelli CL; Giuliani A; Tcheremenskaia O; DeMeo C; Norinder U; Koga H; Jose C; Jeliazkova N; Kochev N; Paskaleva V; Yang C; Daga PR; Clark RD; Rathman J
Mutagenesis; 2019 Mar; 34(1):3-16. PubMed ID: 30357358
[TBL] [Abstract][Full Text] [Related]
3. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
Landry C; Kim MT; Kruhlak NL; Cross KP; Saiakhov R; Chakravarti S; Stavitskaya L
Regul Toxicol Pharmacol; 2019 Dec; 109():104488. PubMed ID: 31586682
[TBL] [Abstract][Full Text] [Related]
4. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
[TBL] [Abstract][Full Text] [Related]
5. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
[TBL] [Abstract][Full Text] [Related]
6. Carbamates and ICH M7 classification: Making use of expert knowledge.
Hemingway R; Fowkes A; Williams RV
Regul Toxicol Pharmacol; 2017 Jun; 86():392-401. PubMed ID: 28385577
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
Araya S; Lovsin-Barle E; Glowienke S
Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
[TBL] [Abstract][Full Text] [Related]
8. Predicting Ames Mutagenicity Using Conformal Prediction in the Ames/QSAR International Challenge Project.
Norinder U; Ahlberg E; Carlsson L
Mutagenesis; 2019 Mar; 34(1):33-40. PubMed ID: 30541036
[TBL] [Abstract][Full Text] [Related]
9. Development of a read-across-derived classification model for the predictions of mutagenicity data and its comparison with traditional QSAR models and expert systems.
Pandey SK; Roy K
Toxicology; 2023 Dec; 500():153676. PubMed ID: 37993082
[TBL] [Abstract][Full Text] [Related]
10. Towards quantitative read across: Prediction of Ames mutagenicity in a large database.
Benigni R
Regul Toxicol Pharmacol; 2019 Nov; 108():104434. PubMed ID: 31374229
[TBL] [Abstract][Full Text] [Related]
11. Validation of Toxtree and SciQSAR in silico predictive software using a publicly available benchmark mutagenicity database and their applicability for the qualification of impurities in pharmaceuticals.
Contrera JF
Regul Toxicol Pharmacol; 2013 Nov; 67(2):285-93. PubMed ID: 23969001
[TBL] [Abstract][Full Text] [Related]
12. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
[TBL] [Abstract][Full Text] [Related]
13. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
Ahlberg E; Amberg A; Beilke LD; Bower D; Cross KP; Custer L; Ford KA; Van Gompel J; Harvey J; Honma M; Jolly R; Joossens E; Kemper RA; Kenyon M; Kruhlak N; Kuhnke L; Leavitt P; Naven R; Neilan C; Quigley DP; Shuey D; Spirkl HP; Stavitskaya L; Teasdale A; White A; Wichard J; Zwickl C; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():1-12. PubMed ID: 26879463
[TBL] [Abstract][Full Text] [Related]
14. Establishing best practise in the application of expert review of mutagenicity under ICH M7.
Barber C; Amberg A; Custer L; Dobo KL; Glowienke S; Van Gompel J; Gutsell S; Harvey J; Honma M; Kenyon MO; Kruhlak N; Muster W; Stavitskaya L; Teasdale A; Vessey J; Wichard J
Regul Toxicol Pharmacol; 2015 Oct; 73(1):367-77. PubMed ID: 26248005
[TBL] [Abstract][Full Text] [Related]
15. In Silico Prediction of Chemically Induced Mutagenicity: A Weight of Evidence Approach Integrating Information from QSAR Models and Read-Across Predictions.
Mombelli E; Raitano G; Benfenati E
Methods Mol Biol; 2022; 2425():149-183. PubMed ID: 35188632
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project.
Furuhama A; Kitazawa A; Yao J; Matos Dos Santos CE; Rathman J; Yang C; Ribeiro JV; Cross K; Myatt G; Raitano G; Benfenati E; Jeliazkova N; Saiakhov R; Chakravarti S; Foster RS; Bossa C; Battistelli CL; Benigni R; Sawada T; Wasada H; Hashimoto T; Wu M; Barzilay R; Daga PR; Clark RD; Mestres J; Montero A; Gregori-Puigjané E; Petkov P; Ivanova H; Mekenyan O; Matthews S; Guan D; Spicer J; Lui R; Uesawa Y; Kurosaki K; Matsuzaka Y; Sasaki S; Cronin MTD; Belfield SJ; Firman JW; Spînu N; Qiu M; Keca JM; Gini G; Li T; Tong W; Hong H; Liu Z; Igarashi Y; Yamada H; Sugiyama KI; Honma M
SAR QSAR Environ Res; 2023; 34(12):983-1001. PubMed ID: 38047445
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained.
Barber C; Cayley A; Hanser T; Harding A; Heghes C; Vessey JD; Werner S; Weiner SK; Wichard J; Giddings A; Glowienke S; Parenty A; Brigo A; Spirkl HP; Amberg A; Kemper R; Greene N
Regul Toxicol Pharmacol; 2016 Apr; 76():7-20. PubMed ID: 26708083
[TBL] [Abstract][Full Text] [Related]
18. An assessment of mutagenicity of chemical substances by (quantitative) structure-activity relationship.
Honma M
Genes Environ; 2020; 42():23. PubMed ID: 32626544
[TBL] [Abstract][Full Text] [Related]
19. Utility of published DNA reactivity alerts.
Myden A; Guesne SJ; Cayley A; Williams RV
Regul Toxicol Pharmacol; 2017 Aug; 88():77-86. PubMed ID: 28549899
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of 11 in silico models for the prediction of small molecule mutagenicity: role of steric hindrance and electron-withdrawing groups.
Ford KA; Ryslik G; Chan BK; Lewin-Koh SC; Almeida D; Stokes M; Gomez SR
Toxicol Mech Methods; 2017 Jan; 27(1):24-35. PubMed ID: 27813437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
